Search

everythinglearnresearchcommunity

for

Search:↓

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Finasteride 1.25 mg showed small improvements in hair density and thickness for female pattern hair loss, but more research is needed.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Hirsutism causes significant psychological distress in women.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Hair loss affects women's self-esteem; treatments like minoxidil can help.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with female pattern hair loss may have a higher risk of developing metabolic syndrome.

Women with irregular periods have a higher risk of heart disease.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.